The largest database of trusted experimental protocols

18 protocols using wst 1

1

HUVEC Viability Assay with RiduROS

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVEC, seeded in 96-well microplates, were treated with RiduROS (0.1, 1, and 10 μg/mL) and the effects on cell viability was monitored at 24 and 48 h after treatment. The viability of HUVEC was assayed by colorimetric assay using WST-1 (Biovision, San Francisco, USA) which was based on cleavage in viable cells of the water-soluble tetrazolium salt WST-1 [2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disul-fonyl)-2H-tetrazolium, monosodium salt] to a formazan dye by mitochondrial dehydrogenase. Briefly, cells cultured in 96-well plates were treated with different concentrations of RiduROS or a single antioxidant component for 24–48 h. Then, 10 μL WST-1 reagent was added to each well and HUVEC were incubated for 4 h at 37°C. The formazan dye produced was quantified by measuring the absorbance of the dye solution at 450 nm with a microplate reader.
+ Open protocol
+ Expand
2

Assessing HUVEC Viability on PLGA Scaffold

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine HUVECs viability during culturing on our PLGA scaffold, a ready-to-use cell proliferation reagent WST-1 (Cat: K304, BioVision, Milpitas, CA, USA) was used. PLGA 50/50 powder was dissolved in acetone in a 1:7 w/w ratio and gently separated onto the flat PDMS mold to make flat PLGA membranes. The flat PLGA membranes were then cut into small circles which fitted the area of the 96 wells and rinsed with 70% alcohol followed by exposed under UV light overnight. Those circular PLGA membranes were then stuck on the bottom of a 96-well dish and coated with 0.5% gelatin. 1500 HUVECs were seeded in each well and WST-1 was used for measuring the increment of cell numbers after culturing for three and seven days.
+ Open protocol
+ Expand
3

Cisplatin Cytotoxicity Assay using WST-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug sensitivity was measured by a WST-1 assay [37 (link)]. Cells were seeded at different cell numbers in a 96-well plate 18 h prior to drug challenge. Cells were pulse-treated with various concentrations of cisplatin for 4 h. The control cells were treated with the solvent of the drug. Total survival of the cells was determined 72 h following drug challenge, and percent survival was estimated by dividing optical absorbance resulted from each experiment group with that of the control group. Each experiment was done in triplicates, and the optical absorbance was measured by coloration of reacted substrate, WST-1 (BioVision, Mountain View, CA), which was catalyzed by mitochondrial dehydrogenases.
+ Open protocol
+ Expand
4

Evaluating anti-c-Src antibody effects on prostate cancer cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prostate cancer cell lines LNCaP, DU-145 and PC-3 were seeded at 2,500 cells per well in 100μL RPMI +5% FBS and cultured overnight in a 96-well plate. Next day, cells were treated with the indicated concentrations (0, 5, 20, 50 μg/mL) of custom anti-c-Src pAb (aa84–110) or rabbit isotype control. Cells were cultured for 72 h before assessing their growth using the cell proliferation reagent WST-1 (Biovision). In brief, 10 μL WST was added to each well and the plate was returned to the 37°C incubator for 60 min. Absorbance at 450nm was measured on a Tecan Infinite M200 Pro and proliferation rate was calculated.
+ Open protocol
+ Expand
5

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 1000, 2500, and 5000 cells/well, 18 hours prior to drug challenge. The cells were then treated continuously with various drug concentrations for 72 hours. The control group was only treated with the drug diluent, PBS or dimethyl sulfoxide. Culture media were replaced with PBS before the addition of 10 μL of WST-1 (BioVision, Mountain View, CA, USA) and incubation was continued for 4 hours. The percentage of surviving cells in the experiment group was quantified and expressed relative to the control group. All procedures were performed in triplicate [8 (link)].
+ Open protocol
+ Expand
6

Cell Viability Assay via WST-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
ULM and/or MM cells were cultured in 96-well plates in complete DMEM-F12 1:1 medium until 80 to 90% confluence. At the end of treatments, WST-1 (BioVision) was added to each well (1:10 dilution) for 2 hours at 37°C, and absorbance was read at 420 nm with reference wavelength set at 650 nm. Data were analyzed following the manufacturer’s manual.
+ Open protocol
+ Expand
7

Cell Viability Assay using WST-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary ULM and MM cells were cultured in 96-well plates. At the end oftreatments, WST-1 (BioVision) was added to each well (1:10 dilution)for4hrs at 37°C, and absorbance was read at 420 nm with referencewavelength set at 650 nm. Data were analyzed following the manufacturer’smanual.
+ Open protocol
+ Expand
8

Drug Sensitivity Assay in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug-sensitivity was measured by a WST-1 assay [40] . Cells were seeded at 100, 1,000, and 5,000 cells/96-well plates 18 hr prior to drug challenge. Cells were pulse-treated with 4 μM of daunorubicin for 2 hr. The negative control cells were treated with the solvent for the drug. Total survival of the cells was determined at 72 hr after the drug challenge, and percent survival was estimated by dividing the optical absorbance resulting from each experimental group with that of the control group. Each experiment was done in triplicate, and the optical absorbance was measured by the coloration of the reacted substrate, WST-1 (BioVision, Mountain View, CA), which was catalyzed by mitochondrial dehydrogenases.
. Statistical analysis.
Overall survival (OS) was de ned as the time from the date of diagnosis to the date of death. Survival curves were plotted using the Kaplan-Meier estimator [41] and the statistical difference in survival between the different groups was compared by a log-rank test [42] . Statistical tests were two-sided, and p < 0.05 was considered signi cant. The t-test was utilized to compare the numerical differences in clinical parameters. Differences in patients' performance status, tumor location, and surgical resection status were assessed by c-square or Fisher's exact test. Analyses of the data were performed using SPSS 10.3 software (Chicago, IL).
+ Open protocol
+ Expand
9

Drug Sensitivity Assay in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug-sensitivity was measured by a WST-1 assay [40] . Cells were seeded at 100, 1,000, and 5,000 cells/96-well plates 18 hr prior to drug challenge. Cells were pulse-treated with 4 μM of daunorubicin for 2 hr. The negative control cells were treated with the solvent for the drug. Total survival of the cells was determined at 72 hr after the drug challenge, and percent survival was estimated by dividing the optical absorbance resulting from each experimental group with that of the control group. Each experiment was done in triplicate, and the optical absorbance was measured by the coloration of the reacted substrate, WST-1 (BioVision, Mountain View, CA), which was catalyzed by mitochondrial dehydrogenases.
. Statistical analysis.
Overall survival (OS) was de ned as the time from the date of diagnosis to the date of death. Survival curves were plotted using the Kaplan-Meier estimator [41] and the statistical difference in survival between the different groups was compared by a log-rank test [42] . Statistical tests were two-sided, and p < 0.05 was considered signi cant. The t-test was utilized to compare the numerical differences in clinical parameters. Differences in patients' performance status, tumor location, and surgical resection status were assessed by c-square or Fisher's exact test. Analyses of the data were performed using SPSS 10.3 software (Chicago, IL).
+ Open protocol
+ Expand
10

Chitosan-Hypericum Perforatum Oil Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chitosan (low molecular weight, degree of deacetylation 85%) was purchased from Sigma. Hypericum perforatum oil (Alvin,Turkey) was purchased from local pharmacy. Acetic acid and ethanol (Merck, Germany) were used as solvents. WST-1 was purchased from Biovision (USA) for cytotoxicity assay. Dulbecco's Modified Eagle Medium (DMEM), fetal bovine serum (FBS), phosphate-buffered saline (PBS), Penicillin-streptomycin antibiotic solution were purchased from Gibco (USA). DAPI (4 , 6-diamidino-2-phenylindole, dihydrochloride) (Cell Signaling, USA) and Alexa Four 488 Phalloidin (Molecular Probes TM ,Thermo Fisher Scientific) stains were used for fluorescence imaging. 37% paraformaldehyde (Merck, Germany) was used for fixation of cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!